Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Lennox-Gastaut syndrome (Disease Or Phenotype)

Omim:MTHU071842

Nci:C84816

Msh:D065768

Mondo:MONDO:16532

Medcin:MEDCIN:312035

Mdr:MDR:10048816

Id:42ffc967-ae52-5fbe-aba9-3835e5ead88d

Icpc2icd10eng:MTHU043230

Icd10cm:G40.81

Chv:CHV:23947

Results found

Linked to

	Label	Description
	Phenobarbital indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	SID11113343 indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	clonazepam indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	lamotrigine indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	primidone indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Clobazam indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Rufinamide indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	phenytoin indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	sulfamic acid (3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-tetrahydro-benzo[1,2-d,3,4-d']bis[1,3]dioxol-3a-ylmethyl ester indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	lorazepam indication Lennox-Gastaut syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Phenobarbital indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

SID11113343 indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

clonazepam indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

lamotrigine indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

primidone indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Clobazam indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Rufinamide indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

phenytoin indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

sulfamic acid (3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-tetrahydro-benzo[1,2-d,3,4-d']bis[1,3]dioxol-3a-ylmethyl ester indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

lorazepam indication Lennox-Gastaut syndrome

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.